These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 11741564)
1. Comparison of physician-managed lipid-lowering care in patients with coronary heart disease in two time periods (1994 and 1999). Smith DA; Harnick D; Kilaru R Am J Cardiol; 2001 Dec; 88(12):1417-9, A6. PubMed ID: 11741564 [No Abstract] [Full Text] [Related]
2. Time trend analysis and variations in prescribing lipid lowering drugs in general practice. Baxter C; Jones R; Corr L BMJ; 1998 Oct; 317(7166):1134-5. PubMed ID: 9784452 [No Abstract] [Full Text] [Related]
3. Effects of practice setting on quality of lipid-lowering management in patients with coronary artery disease. Harnick DJ; Cohen JL; Schechter CB; Fuster V; Smith DA Am J Cardiol; 1998 Jun; 81(12):1416-20. PubMed ID: 9645890 [TBL] [Abstract][Full Text] [Related]
4. Patients with acute coronary syndrome should start a statin while still in hospital. Isles CG Heart; 2002 Jul; 88(1):5-6. PubMed ID: 12067927 [No Abstract] [Full Text] [Related]
5. Effectiveness of lipid-lowering medications in outpatients with coronary heart disease in the Department of Veterans Affairs System. Rubins HB; Nelson DB; Noorbaloochi S; Nugent S Am J Cardiol; 2003 Nov; 92(10):1177-82. PubMed ID: 14609592 [TBL] [Abstract][Full Text] [Related]
6. Effect of coronary angiography on use of lipid-lowering agents in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. For the WISE Investigators. Bittner V; Olson M; Kelsey SF; Rogers WJ; Bairey Merz CN; Armstrong K; Reis SE; Boyette A; Sopko G Am J Cardiol; 2000 May; 85(9):1083-8. PubMed ID: 10781756 [TBL] [Abstract][Full Text] [Related]
7. Secondary prevention in a cardiology group practice and hospital setting after a heart-care initiative. LaBresh KA; Owen P; Alteri C; Reilly S; Albright PS; Hordes AR; Shaftel PA; Noonan TE; Stoukides CA; Kaul AF Am J Cardiol; 2000 Feb; 85(3A):23A-29A. PubMed ID: 10695704 [TBL] [Abstract][Full Text] [Related]
8. Physicians' attitudes toward preventive therapy for coronary artery disease: is there a gender bias? Abuful A; Gidron Y; Henkin Y Clin Cardiol; 2005 Aug; 28(8):389-93. PubMed ID: 16144216 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of therapeutic inertia in lipid lowering treatment of primary care patients with high cardiovascular risk]. de Pablos Vicente MA; Leal Hernández M; Balanza Galindo S; Abellán Alemán J Aten Primaria; 2012 Mar; 44(3):e14-5. PubMed ID: 21724299 [No Abstract] [Full Text] [Related]
10. Treatment of Dyslipidemia in Elderly Patients With Coronary Heart Disease: There Are Miles to Go Before We Sleep. Toth PP J Am Coll Cardiol; 2015 Oct; 66(17):1873-5. PubMed ID: 26493658 [No Abstract] [Full Text] [Related]
11. Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease: A Retrospective Cohort Study in the Medicare Population 2007 to 2011. Bittner V; Deng L; Rosenson RS; Taylor B; Glasser SP; Kent ST; Farkouh ME; Muntner P J Am Coll Cardiol; 2015 Oct; 66(17):1864-72. PubMed ID: 26493657 [TBL] [Abstract][Full Text] [Related]
12. Association of Frequency of Lipid Testing With Changes in Lipid-Lowering Therapy. Stenehjem K; Herren D; Pulver G; Combs B JAMA Intern Med; 2017 Oct; 177(10):1529-1531. PubMed ID: 28846768 [TBL] [Abstract][Full Text] [Related]
13. Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study. García Ruiz FJ; Marín Ibáñez A; Pérez-Jiménez F; Pintó X; Nocea G; Ahumada C; Alemao E; Yin D; Pharmacoeconomics; 2004; 22 Suppl 3():1-12. PubMed ID: 15669149 [TBL] [Abstract][Full Text] [Related]
14. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey. Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D; Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002 [TBL] [Abstract][Full Text] [Related]
15. Role of Patient and Practice Characteristics in Variance of Treatment Quality in Type 2 Diabetes between General Practices. Cho YY; Sidorenkov G; Denig P PLoS One; 2016; 11(11):e0166012. PubMed ID: 27806107 [TBL] [Abstract][Full Text] [Related]
16. In-hospital initiation of lipid-lowering therapy for patients with coronary heart disease: the time is now. Fonarow GC; Ballantyne CM Circulation; 2001 Jun; 103(23):2768-70. PubMed ID: 11401927 [No Abstract] [Full Text] [Related]
17. Are patients suffering from stable angina receiving optimal medical treatment? Beaulieu MD; Blais R; Jacques A; Battista RN; Lebeau R; Brophy J QJM; 2001 Jun; 94(6):301-8. PubMed ID: 11391028 [TBL] [Abstract][Full Text] [Related]
18. Use of evidence-based medical therapy in patients undergoing percutaneous coronary revascularization in the United States, Europe, and Canada. Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I) and Canadian Coronary Atherectomy Trial (CCAT) investigators. Eisenberg MJ; Califf RM; Cohen EA; Adelman AG; Mark DB; Topol EJ Am J Cardiol; 1997 Apr; 79(7):867-72. PubMed ID: 9104896 [TBL] [Abstract][Full Text] [Related]
19. Association between primary care physicians' evidence-based medicine knowledge and quality of care. Shuval K; Linn S; Brezis M; Shadmi E; Green ML; Reis S Int J Qual Health Care; 2010 Feb; 22(1):16-23. PubMed ID: 19951965 [TBL] [Abstract][Full Text] [Related]
20. Patterns and effectiveness of lipid-lowering therapies in a managed care environment. Meyer JW; Schultz JS; O'Donnell JC; Patel PA; Sasane RM Value Health; 2005; 8(5):601-12. PubMed ID: 16176498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]